Nano ZnO@PEG catalyzed one-pot green synthesis of pyrano[2,3-d]pyrimidines in ethanol via one-pot multicomponent approach

[1]  Yingxia Li,et al.  Synthesis and biological evaluation of novel 1-substituted 3-(3-phenoxyprop-1-yn-1-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amines as potent Bruton's tyrosine kinase (BTK) inhibitors. , 2019, Bioorganic & medicinal chemistry letters.

[2]  A. Guirado,et al.  Therapeutic potential of pteridine derivatives: A comprehensive review , 2018, Medicinal research reviews.

[3]  D. Pinheiro,et al.  Electrochemical synthesis, photodegradation and antibacterial properties of PEG capped zinc oxide nanoparticles. , 2018, Journal of photochemistry and photobiology. B, Biology.

[4]  S. Tabassum,et al.  Citric‐Acid‐Catalyzed Green and Sustainable Synthesis of Novel Functionalized Pyrano[2, 3‐e]pyrimidin‐ and Pyrano[2, 3‐d]pyrazol‐amines in Water via One‐Pot Multicomponent Approaches , 2018 .

[5]  T. Farghaly,et al.  Triazolopyrimidines and Thiazolopyrimidines: Synthesis, Anti-HSV-1, Cytotoxicity and Mechanism of Action. , 2017, Mini reviews in medicinal chemistry.

[6]  I. Hassan,et al.  Proficient synthesis of bioactive annulated pyrimidine derivatives: A review , 2017 .

[7]  Ebrahim Mollashahi,et al.  Nano-SiO2 catalyzed three-component preparations of pyrano[2,3-d]pyrimidines, 4H-chromenes, and dihydropyrano[3,2-c]chromenes , 2017 .

[8]  Jeffrey T. Kuethe,et al.  Discovery of N-[Bis(4-methoxyphenyl)methyl]-4-hydroxy-2-(pyridazin-3-yl)pyrimidine-5-carboxamide (MK-8617), an Orally Active Pan-Inhibitor of Hypoxia-Inducible Factor Prolyl Hydroxylase 1-3 (HIF PHD1-3) for the Treatment of Anemia. , 2016, Journal of medicinal chemistry.

[9]  A. Shalla,et al.  Dibutylamine (DBA): A highly efficient catalyst for the synthesis of pyrano[2,3-d]pyrimidine derivatives in aqueous media , 2016 .

[10]  L. Edjlali,et al.  Titanium dioxide nanoparticles as efficient catalyst for the synthesis of pyran’s annulated heterocyclic systems via three-component reaction , 2016, Monatshefte für Chemie - Chemical Monthly.

[11]  R. Yousefi,et al.  Novel curcumin-based pyrano[2,3-d]pyrimidine anti-oxidant inhibitors for α-amylase and α-glucosidase: Implications for their pleiotropic effects against diabetes complications. , 2015, International journal of biological macromolecules.

[12]  C. Ganesh Kumar,et al.  One-pot three-component domino protocol for the synthesis of novel pyrano[2,3-d]pyrimidines as antimicrobial and anti-biofilm agents. , 2015, Organic & biomolecular chemistry.

[13]  M. R. Shishehbore,et al.  Nano-sawdust-OSO3H as a new, cheap and effective nanocatalyst for one-pot synthesis of pyrano[2,3-d]pyrimidines , 2015, Journal of the Iranian Chemical Society.

[14]  S. Maddila,et al.  Mn doped ZrO2 as a green, efficient and reusable heterogeneous catalyst for the multicomponent synthesis of pyrano[2,3-d]-pyrimidine derivatives , 2015 .

[15]  J. Albadi,et al.  Eco-friendly synthesis of pyrano[2,3-d]pyrimidinone derivatives catalyzed by a novel nanocatalyst of ZnO-supported copper oxide in water , 2015, Research on chemical intermediates (Print).

[16]  B. Sabour,et al.  Al-HMS-20 catalyzed synthesis of pyrano[2,3-d]pyrimidines and pyrido[2,3-d]pyrimidines via three-component reaction , 2015, Research on Chemical Intermediates.

[17]  Jeroen S. Dickschat,et al.  2H-Pyran-2-ones from Trichoderma viride and Trichoderma asperellum , 2013 .

[18]  A. R. Saundane,et al.  Synthesis of novel 2-amino-4-(5'-substituted 2'-phenyl-1H-indol-3'-yl)-6-aryl-4H-pyran-3-carbonitrile derivatives as antimicrobial and antioxidant agents. , 2013, Bioorganic & medicinal chemistry letters.

[19]  Ghodsi Mohammadi Ziarani,et al.  Three-component synthesis of pyrano[2,3-d]-pyrimidine dione derivatives facilitated by sulfonic acid nanoporous silica (SBA-Pr-SO3H) and their docking and urease inhibitory activity , 2013, DARU Journal of Pharmaceutical Sciences.

[20]  Duane D. Miller,et al.  New substituted 4H-chromenes as anticancer agents. , 2012, Bioorganic & medicinal chemistry letters.

[21]  M. Kamal,et al.  Efficient one-pot preparation of novel fused chromeno[2,3-d]pyrimidine and pyrano[2,3-d]pyrimidine derivatives. , 2012, European journal of medicinal chemistry.

[22]  A. Venkatesham,et al.  Synthesis of new chromeno-annulated cis-fused pyrano[3,4-c]pyran derivatives via domino Knoevenagel–hetero-Diels–Alder reactions and their biological evaluation towards antiproliferative activity , 2012 .

[23]  H. Swart,et al.  Synthesis and characterization of ZnO nanoparticles using polyethylene glycol (PEG) , 2012 .

[24]  Jigar A. Makawana,et al.  Synthesis and Antimicrobial Evaluation of New Pyrano[4,3‐b]pyran and Pyrano[3,2‐c]chromene Derivatives Bearing a 2‐Thiophenoxyquinoline Nucleus , 2012, Archiv der Pharmazie.

[25]  Tetsuro Ito,et al.  Novel quinolinone alkaloids bearing a lignoid moiety and related constituents in the leaves of Melicope denhamii , 2012 .

[26]  M. Kidwai,et al.  Magnetic nanoparticles catalyzed synthesis of diverse N-Heterocycles , 2011, Molecular Diversity.

[27]  Tetsuro Ito,et al.  Melicodenines A and B, novel Diels–Alder type adducts isolated from Melicope denhamii , 2011 .

[28]  Sung-Hoon Kim,et al.  Photoswitching of bisthienylethene using 2D-π-A type pyran-based fluorescent dye for rewritable optical storage , 2011 .

[29]  Y. R. Lee,et al.  Environmentally benign, one-pot synthesis of pyrans by domino Knoevenagel/6π-electrocyclization in water and application to natural products , 2010 .

[30]  M. Mohamed,et al.  Synthesis and biological evaluation of some thio containing pyrrolo [2,3-d]pyrimidine derivatives for their anti-inflammatory and anti-microbial activities. , 2010, European journal of medicinal chemistry.

[31]  H. Soliman,et al.  Pyrazolopyranopyrimidines as a Class of Anti-Inflammatory Agents , 2006, Zeitschrift fur Naturforschung. C, Journal of biosciences.

[32]  Ying Zhao,et al.  A Clean One-pot Synthesis of 7-Amino-5-Aryl-6-Cyano-1,5-Dihydro-2H-Pyrano[2,3-d] Pyrimidine-2,4(3H)-Diones in Aqueous Media under Ultrasonic Irradiation , 2005 .

[33]  L. Sorbera,et al.  Ambrisentan : Treatment of pulmonary arterial hypertension endothelin ETA receptor antagonist , 2005 .

[34]  D. Shi,et al.  Effective Synthesis of 7‐Amino‐6‐cyano‐5‐aryl‐5H‐pyrano[2,3‐d]pyrimidine‐2,4(1H,3H)‐diones Under Microwave Irradiation , 2004 .

[35]  P. Bhuyan,et al.  A novel three-component one-pot synthesis of pyrano[2,3-d]pyrimidines and pyrido[2,3-d]pyrimidines using microwave heating in the solid state , 2003 .

[36]  K. Jacobson,et al.  Purine and pyrimidine (P2) receptors as drug targets. , 2002, Journal of medicinal chemistry.

[37]  A. Gotto,et al.  Comparison of effects on low-density lipoprotein cholesterol and high-density lipoprotein cholesterol with rosuvastatin versus atorvastatin in patients with type IIa or IIb hypercholesterolemia. , 2002, The American journal of cardiology.

[38]  A. Bedair,et al.  Synthesis and antimicrobial activities of novel naphtho[2,1-b]pyran, pyrano[2,3-d]pyrimidine and pyrano[3,2-e][1,2,4]triazolo[2,3-c]-pyrimidine derivatives. , 2001, Farmaco.

[39]  P. Waterman,et al.  3-Monoterpenyl-2,4-dioxygenated quinoline alkaloids from the aerial parts of Halfordia kendack. , 2001, Phytochemistry.

[40]  S. Srinivasula,et al.  Structure-based discovery of an organic compound that binds Bcl-2 protein and induces apoptosis of tumor cells. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[41]  R. W. Fleming,et al.  Antihypertensive activity of 6-arylpyrido[2,3-d]pyrimidin-7-amine derivatives. , 1981, Journal of medicinal chemistry.

[42]  S. Lee,et al.  Synthesis and antitumor activity of 2,4-diamino-6-(2,5-dimethoxybenzyl)-5-methylpyrido[2,3-d]pyrimidine. , 1980, Journal of medicinal chemistry.

[43]  E. Elslager,et al.  Folate antagonists. 4. Antimalarial and antimetabolite effects of 2,4-diamino-6-((benzyl)amino)pyrido(2,3-d)-pyrimidines. , 1972, Journal of medicinal chemistry.